New models of neoplastic progression in Barrett's oesophagus

Biochemical Society Transactions

Volumn 38, Issue 2, 2010, Pages 331-336

  Pavlov, Kirill ^a   Maley, Carlo C ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b WISTAR INSTITUTE   (United States)

Author keywords

Anastamosis; Barrett's oesophagus; Cancer prevention; Disease model; Neoplastic progression; Oesophageal adenocarcinoma

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN P53;

ANEUPLOIDY; BARRETT ESOPHAGUS; ESOPHAGEAL ADENOCARCINOMA; EXPERIMENTAL MODEL; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; INTESTINE METAPLASIA; MATHEMATICAL MODEL; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL; TISSUE CULTURE; ANIMAL; BIOLOGY; DISEASE COURSE; DISEASE MODEL; DOG; ESOPHAGUS TUMOR; METHODOLOGY; MOUSE; PATHOLOGY; RAT; THEORETICAL MODEL; TISSUE CULTURE TECHNIQUE;

ANIMALIA; RATTUS;

ANIMALS; BARRETT ESOPHAGUS; COMPUTATIONAL BIOLOGY; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOGS; ESOPHAGEAL NEOPLASMS; HUMANS; MICE; MODELS, THEORETICAL; RATS; TISSUE CULTURE TECHNIQUES;

EID: 77953268500     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0380331     Document Type: Review

References (53)

1. Haggitt, R.C. (1994) Barrett's esophagus, dysplasia, and adenocarcinoma. Hum. Pathol. 25, 982-993
2. Jankowski, J.A. and Anderson, M. (2004) Management of oesophageal adenocarcinoma: control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus. Aliment. Pharmacol. Ther. 20, (Suppl. 5), 71-80
3. Leedham, S. and Jankowski, J. (2007) The evidence base of proton pump inhibitor chemopreventative agents in Barrett's esophagus: the good, the bad, and the flawed! Am. J. Gastroenterol. 102, 21-23 (Pubitemid 46072038)
4. Adler, D.C., Zhou, C., Tsai, T.H., Lee, H.C., Becker, L., Schmitt, J.M., Huang, Q., Fujimoto, J.G. and Mashimo, H. (2009) Three-dimensional optical coherence tomography of Barrett's esophagus and buried glands beneath neosquamous epithelium following radiofrequency ablation. Endoscopy 41, 773-776
5. Orlando, R.C. (2006) Mucosal defense in Barrett's esophagus. In Barrett's Esophagus and Esophageal Adenocarcinoma (Sharma, P. and Sampliner, R., eds) pp. 60-72, Blackwell Publishing, Oxford
6. Jovov, B., Van Itallie, C.M., Shaheen, N.J., Carson, J.L., Gambling, T.M., Anderson, J.M. and Orlando, R.C. (2007) Claudin-18: a dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G1106-G1113
7. Tobey, N.A., Argote, C.M., Vanegas, X.C., Barlow, W. and Orlando, R.C. (2007) Electrical parameters and ion species for active transport in human esophageal stratified squamous epithelium and Barrett's specialized columnar epithelium. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G264-G270
8. Thomas, T., Abrams, K.R., De Caestecker, J.S. and Robinson, R.J. (2007) Meta analysis: cancer risk in Barrett's oesophagus. Aliment. Pharmacol. Ther. 26, 1465-1477
9. Merlo, L.M., Pepper, J.W., Reid, B.J. and Maley, C.C. (2006) Cancer as an evolutionary and ecological process. Nat. Rev. Cancer 6, 924-935
10. Pepper, J., Findlay, C.S., Kassen, R., Spencer, S. and Maley, C. (2009) Cancer research meets evolutionary biology. Evol. Appl. 2, 62-70
11. Maley, C.C. and Forrest, S. (2000) Exploring the relationship between neutral and selective mutations in cancer. Artif. Life 6, 325-345
12. Maley, C.C., Galipeau, P.C., Li, X., Sanchez, C.A., Paulson, T.G., Blount, P.L. and Reid, B.J. (2004) The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res. 64, 7629-7633 (Pubitemid 39372110)
13. Chao, D.L., Eck, J.T., Brash, D.E., Maley, C.C. and Luebeck, E.G. (2008) Preneoplastic lesion growth driven by the death of adjacent normal stem cells. Proc. Natl. Acad. Sci. U.S.A. 105, 15034-15039
14. van Leeuwen, I.M., Byrne, H.M., Jensen, O.E. and King, J.R. (2006) Crypt dynamics and colorectal cancer: advances in mathematical modelling. Cell Prolif. 39, 157-181 (Pubitemid 43910548)
15. van Leeuwen, I.M., Edwards, C.M., Ilyas, M. and Byrne, H.M. (2007) Towards a multiscale model of colorectal cancer. World J. Gastroenterol. 13, 1399-1407
16. Pepper, J.W., Sprouffske, K. and Maley, C.C. (2007) Animal cell differentiation patterns suppress somatic evolution. PLoS Comput. Biol. 3, e250
17. Loeffler, M. and Roeder, I. (2004) Conceptual models to understand tissue stem cell organization. Curr. Opin. Hematol. 11, 81-87
18. Johnston, M.D., Edwards, C.M., Bodmer, W.F., Maini, P.K. and Chapman, S.J. (2007) Mathematical modeling of cell population dynamics in the colonic crypt and in colorectal cancer. Proc. Natl. Acad. Sci. U.S.A. 104, 4008-4013
19. d'Onofrio, A. and Tomlinson, I.P. (2007) A nonlinear mathematical model of cell turnover, differentiation and tumorigenesis in the intestinal crypt. J. Theor. Biol. 244, 367-374
20. Boman, B.M., Fields, J.Z., Cavanaugh, K.L., Guetter, A. and Runquist, O.A. (2008) How dysregulated colonic crypt dynamics cause stem cell overpopulation and initiate colon cancer. Cancer Res. 68, 3304-3313
21. Meineke, F.A., Potten, C.S. and Loeffler, M. (2001) Cell migration and organization in the intestinal crypt using a lattice-free model. Cell Prolif. 34, 253-266
22. Loeffler, M., Birke, A., Winton, D. and Potten, C. (1993) Somatic mutation, monoclonality and stochastic models of stem cell organization in the intestinal crypt. J. Theor. Biol. 160, 471-491
23. Loeffler, M., Bratke, T., Paulus, U., Li, Y.Q. and Potten, C.S. (1997) Clonality and life cycles of intestinal crypts explained by a state dependent stochastic model of epithelial stem cell organization. J. Theor. Biol. 186, 41-54
24. Totafurno, J., Bjerknes, M. and Cheng, H. (1987) The crypt cycle: crypt and villus production in the adult intestinal epithelium. Biophys. J. 52, 279-294
25. Kong, J., Nakagawa, H., Isariyawongse, B.K., Funakoshi, S., Silberg, D.G., Rustgi, A.K. and Lynch, J.P. (2009) Induction of intestinalization in human esophageal keratinocytes is a multistep process. Carcinogenesis 30, 122-130
26. Palanca-Wessels, M.C., Barrett, M.T., Galipeau, P.C., Rohrer, K.L., Reid, B.J. and Rabinovitch, P.S. (1998) Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities. Gastroenterology 114, 295-304
27. Palanca-Wessels, M.C., Klingelhutz, A., Reid, B.J., Norwood, T.H., Opheim, K.E., Paulson, T.G., Feng, Z. and Rabinovitch, P.S. (2003) Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model. Carcinogenesis 24, 1183-1190 (Pubitemid 36927058)
28. Jaiswal, K.R., Morales, C.P., Feagins, L.A., Gandia, K.G., Zhang, X., Zhang, H.Y., Hormi-Carver, K., Shen, Y., Elder, F., Ramirez, R.D. et al. (2007) Characterization of telomerase-immortalized, non-neoplastic, human Barrett's cell line (BAR-T). Dis. Esophagus 20, 256-264 (Pubitemid 46831260)
29. Alvarez, H., Koorstra, J.B., Hong, S.M., Boonstra, J.J., Dinjens, W.N., Wu, T.T., Montgomery, E., Eshleman, J.R. and Maitra, A. (2008) Establishment and characterization of a bona fide Barrett esophagus-associated adenocarcinoma cell line. Cancer Biol. Ther. 7, 1753-1755
30. Soldes, O.S., Kuick, R.D., Thompson, II, I.A., Hughes, S.J., Orringer, M.B., Iannettoni, M.D., Hanash, S.M. and Beer, D.G. (1999) Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas. Br. J. Cancer 79, 595-603
31. Souza, R.F., Shewmake, K., Beer, D.G., Cryer, B. and Spechler, S.J. (2000) Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Res. 60, 5767-5772
32. Boonstra, J.J., van der Velden, A.W., Beerens, E.C., van Marion, R., Morita-Fujimura, Y., Matsui, Y., Nishihira, T., Tselepis, C., Hainaut, P., Lowe, A.W. et al. (2007) Mistaken identity of widely used esophageal adenocarcinoma cell line TE-7. Cancer Res. 67, 7996-8001 (Pubitemid 47395132)
33. Beacham, D.A. and Cukierman, E. (2005) Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression. Semin. Cancer Biol. 15, 329-341
34. Okawa, T., Michaylira, C.Z., Kalabis, J., Stairs, D.B., Nakagawa, H., Andl, C.D., Johnstone, C.N., Klein-Szanto, A.J., El-Deiry, W.S., Cukierman, E. et al. (2007) The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation. Genes Dev. 21, 2788-2803 (Pubitemid 350070724)
35. Stairs, D.B., Nakagawa, H., Klein-Szanto, A., Mitchell, S.D., Silberg, D.G., Tobias, J.W., Lynch, J.P. and Rustgi, A.K. (2008) Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus. PLoS ONE 3, e3534
36. Sato, T., Vries, R.G., Snippert, H.J., van de Wetering, M., Barker, N., Stange, D.E., van Es, J.H., Abo, A., Kujala, P., Peters, P.J. and Clevers, H. (2009) Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262-265
37. Koak, Y. and Winslet, M. (2002) Changing role of in vivo models in columnar-lined lower esophagus. Dis. Esophagus 15, 271-277
38. Li, Y. and Martin, 2nd, R.C. (2007) Reflux injury of esophageal mucosa: experimental studies in animal models of esophagitis, Barrett's esophagus and esophageal adenocarcinoma. Dis. Esophagus 20, 372-378
39. Goldstein, S.R., Yang, G.Y., Chen, X., Curtis, S.K. and Yang, C.S. (1998) Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma. Carcinogenesis 19, 1445-1449 (Pubitemid 28409843)
40. Chen, X., Wang, S., Wu, N., Sood, S., Wang, P., Jin, Z., Beer, D.G., Giordano, T.J., Lin, Y., Shih, W.C. et al. (2004) Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis. Clin. Cancer Res. 10, 6703-6709
41. Chen, X., Yang, G., Ding, W.Y., Bondoc, F., Curtis, S.K. and Yang, C.S. (1999) An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload. Carcinogenesis 20, 1801-1808
42. Su, Y., Chen, X., Klein, M., Fang, M., Wang, S., Yang, C.S. and Goyal, R.K. (2004) Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: similarity to human Barrett's esophagus. Lab. Invest. 84, 753-765
43. Galipeau, P.C., Li, X., Blount, P.L., Maley, C.C., Sanchez, C.A., Odze, R.D., Ayub, K., Rabinovitch, P.S., Vaughan, T.L. and Reid, B.J. (2007) NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. PLoS Med. 4, e67
44. Xu, X., LoCicero, 3rd, J., Macri, E., Loda, M. and Ellis, Jr, F.H. (2000) Barrett's esophagus and associated adenocarcinoma in a mouse surgical model. J. Surg. Res. 88, 120-124
45. Crawford, S.E., Stellmach, V., Murphy-Ullrich, J.E., Ribeiro, S.M., Lawler, J., Hynes, R.O., Boivin, G.P. and Bouck, N. (1998) Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 93, 1159-1170
46. Gillen, P., Keeling, P., Byrne, P.J., West, A.B. and Hennessy, T.P. (1988) Experimental columnar metaplasia in the canine oesophagus. Br. J. Surg. 75, 113-115
47. Pollara, W.M., Cecconello, I., Zilberstein, B., Iria, K. and Pinotti, H.W. (1983) Regeneration of esophageal epithelium in the presence of gastroesophageal reflux. Arq. Gastroenterol. 20, 53-59
48. Meza, R., Jeon, J., Moolgavkar, S.H. and Luebeck, E.G. (2008) Age-specific incidence of cancer: phases, transitions, and biological implications. Proc. Natl. Acad. Sci. U.S.A. 105, 16284-16289
49. Beerenwinkel, N., Antal, T., Dingli, D., Traulsen, A., Kinzler, K.W., Velculescu, V.E., Vogelstein, B. and Nowak, M.A. (2007) Genetic progression and the waiting time to cancer. PLoS Comput. Biol. 3, e225
50. Zhang, W., Hanks, A.N., Boucher, K., Florell, S.R., Allen, S.M., Alexander, A., Brash, D.E. and Grossman, D. (2005) UVB-induced apoptosis drives clonal expansion during skin tumor development. Carcinogenesis 26, 249-257 (Pubitemid 40207720)
51. van Oijen, M.G. and Slootweg, P.J. (2000) Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits? Cancer Epidemiol. Biomarkers Prev. 9, 249-256
52. Potter, J.D. (1997) β-Carotene and the role of intervention studies. Cancer Lett. 114, 329-331
53. Maley, C.C., Reid, B.J. and Forrest, S. (2004) Cancer prevention strategies that address the evolutionary dynamics of neoplastic cells: simulating benign cell boosters and selection for chemosensitivity. Cancer Epidemiol. Biomarkers Prev. 13, 1375-1384